Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2024-03-24 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司关于锦好医疗2023年募集资金存放与实际使用情况的专项核查意见
Regulatory Filings
2024-03-24 Chinese
关于大信会计师事务所（特殊普通合伙）履职情况评估的报告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the appointment and evaluation of the audit firm (DaXin CPA Firm) for the company's 2023 annual audit. It describes the audit firm's qualifications, the audit process, and confirms that the audit was completed with an unqualified opinion. The document does not contain the full audit report or detailed financial statements but rather discusses the audit engagement and results. The length is short (1402 characters), and it serves as an announcement about the audit work and the auditor's independence and performance. Therefore, it fits best under 'Audit Report / Information (AR)' as it is a standalone audit-related announcement, not the full annual report or just a regulatory filing or report publication announcement. FY 2023
2024-03-24 Chinese
2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as an "年度报告摘要" which translates to "Annual Report Summary" and contains detailed financial data for the year 2023, including assets, net profit, earnings per share, and shareholder information. It references the full annual report and includes an audit opinion from a certified accounting firm. The content covers company business overview, financial performance, shareholder structure, and dividend distribution plans, all typical components of an Annual Report. The document length is over 5,000 characters and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-03-24 Chinese
2023年独立董事述职报告（丘小乐）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2023" from Huizhou Jin Hao Medical Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions expressed, investigations into company management, training attended, and efforts to protect investor rights during the year 2023. The content focuses on the independent director's duties and activities rather than financial results or corporate governance structure changes. It is a report on the independent director's work and oversight rather than a general management report or audit report. This type of document is best classified under Board/Management Information (MANG) as it relates to board members' activities and governance roles, specifically the independent director's report on their duties and opinions.
2024-03-24 Chinese
第三届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the second meeting of the third board of directors of Huizhou Jin Hao Medical Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various reports such as the 2023 Annual Report, Audit Report, and other management reports. The document repeatedly states that these reports are disclosed separately on the Beijing Stock Exchange platform with specific announcement numbers, indicating that this document itself is not the reports but a formal announcement of board meeting decisions. The content focuses on board meeting resolutions rather than the full annual report or audit report itself. Therefore, this document fits the category of Board/Management Information (MANG), as it announces board meeting decisions and management reports rather than containing the reports themselves.
2024-03-24 Chinese
2023年独立董事述职报告（袁英红）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for 2023" from Huizhou Jin Hao Medical Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions on board resolutions, participation in training, and efforts to protect shareholder rights during the year 2023. The content is a narrative report on the independent director's duties and activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or a regulatory filing. This type of document is best classified under Board/Management Information (MANG) as it relates to board member activities and governance roles.
2024-03-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.